InsidersTradesSigma
Track the 셀리드 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 셀리드 has recorded 57 insider filings. The latest transaction was disclosed on 14 July 2026 (Other). Among the most active insiders: 강창율. All data is openly available.
57
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
21 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 July 2026
Declarations57 total
1,683,277 sharesKRXDART:20240814003596
1,683,277 sharesKRXDART:20240620000131
1,683,277 sharesKRXDART:20231220000214
25 of 57 declarations
关于 셀리드
셀리드 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发疾病治疗的创新解决方案。